Aimee AI Health Companion
24/7 AI weight loss and lifestyle concierge
Company profile
Company profile
Found is a telehealth weight loss company that delivers personalized, medication-assisted weight care programs designed by experts in obesity medicine. The platform provides members with access to board-certified clinicians who prescribe and manage GLP-1 medications such as compounded tirzepatide, compounded semaglutide, Wegovy, Zepbound, Mounjaro, and Ozempic, along with other weight loss medications like Metformin. Found's comprehensive approach combines prescription medication with behavioral support, lifestyle coaching, and an AI health companion called Aimee. The company serves over 300,000 members and accepts insurance from major providers across most U.S. states, with copays typically under $30 per visit for insured members. Cash-pay options are also available. Found's program is built on a proprietary metabolic health assessment called MetabolicPrint, which helps clinicians create personalized treatment plans. Members receive ongoing support through monthly check-ins with providers, 24/7 access to their care team, and a supportive member community. The company reports that members lose an average of 12% body weight after one year, with 83% sustaining results long-term. Found also partners with health plans and employers to provide weight care programs that aim to improve health outcomes while managing GLP-1 medication costs. The company's mission is to transform how society treats, manages, and talks about weight by making doctor-designed weight loss accessible for everyone.
Company description Found official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Serves over 300,000 members. Launched Foundayo (orforglipron) medication option. Introduced GLP-1 microdosing program. Expanded insurance coverage to 1 in 3 Americans.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
24/7 AI weight loss and lifestyle concierge
B2B weight care program for health plans and employers
Personalized weight loss program with GLP-1 medications and comprehensive care
Orforglipron-based weight loss medication option
Simplified way to start GLP-1 medication with lower doses
Personalized metabolic health assessment tool
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
NCT04795934 · Mentioned · ACTIVE NOT RECRUITING
Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use DisorderNCT06269627 · Mentioned · RECRUITING
Efficacy of the E-motional Training Program for Improving Social Cognition in People With Dual Pathology in a Clinical and Prison EnvironmentNCT06514937 · Mentioned · COMPLETED
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaNCT06172296 · Mentioned · RECRUITING
Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of SaruparibNCT06899061 · Mentioned · ACTIVE NOT RECRUITING
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of HypertensionNCT06559891 · Mentioned · RECRUITING
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
at 1 year for users reporting weight weekly
at 12 months
sustaining results for one year
at month 3 by almost half of members
per patient with diabetes
per patient with mental health disorders
per patient with back pain
versus 20% average for employee wellness programs
by Found members total
Consistent weight loss
49 lbs lost through consistency
Weight loss and life transformation
280 lbs lost - best version of myself in over 20 years
Weight loss and sleep apnea resolution
120 lbs lost, no longer has sleep apnea, sleeping much better
Weight loss and life improvement
43 lbs lost - huge difference in life
Finding missing link in weight loss journey
35 lbs lost - found the missing link in life
Weight loss and quality of life improvement
80 lbs lost - living a more productive, happy, and full life
05 · Leadership
Leadership profiles and professional links from the current Company record.
Dr. Kumar
Senior Medical Advisor
06 · Company updates
Recent articles published on Found's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
Integration of telomere length analysis and genetic sequencing into routine practice is changing diagnoses and treatment decisions for lung disease patients
Clinical AI · Jul 3, 2026
New national registry standardizes pharmaceutical data across the world's most populous nation, creating infrastructure for AI-driven clinical tools and medication safety systems.
Policy & Regulation · Jul 3, 2026
FDA approval of Tryngolza for ultra-rare pancreatitis disorder and major partnership for hereditary angioedema treatment signal growing confidence in antisense oligonucleotide technology.
Drug Discovery & Research · Jul 3, 2026
Pooling mental health data across twelve isolated mountain communities reveals hidden behavioral health crises driven by seasonal work instability and geographic isolation.
Mental & Behavioral Health · Jun 26, 2026
Mechanistic AI that explains *why* drugs work—rather than just predicting outcomes—could finally give regulators the transparency needed to accelerate drug development and reduce catastrophic trial failures.
Drug Discovery & Research · Jun 26, 2026
Analysis of 2.3 million veterans reveals the updated vaccine formulation may offer unexpected cardiovascular protection alongside infection prevention benefits.
Clinical AI · Jun 26, 2026
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to optimize metabolic health, provide personalized nutrition recommendations, or analyze metabolic responses to food for generally healthy or non-diabetic populations. Emphasizes wellness, performance optimization, and preventive health rather than management of a diagnosed disease.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.